RXRX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Recursion Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 3.58 USD 2.29% Market Closed

Market Cap: $2.1B

	Recursion Pharmaceuticals Inc NASDAQ:RXRX	US
A	African Rainbow Minerals Ltd SWB:EB9	ZA
	Windar Photonics PLC LSE:WPHO	DK
S	Schneider Electric SE DUS:SND	FR

Profitability Summary

Recursion Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

29%

Low 3Y Average Gross Margin

Gross Margin is Increasing

8% > 29%

Negative Operating Margin

-725%

Negative 3Y Average Operating Margin

-908%

Declining Operating Margin

-657% > -725%

Negative Net Margin

-697%

Negative 3Y Average Net Margin

-882%

Declining Net Margin

-618% > -697%

Negative Free Cash Flow Margin

-458%

Negative 3Y Average Free Cash Flow Margin

-635%

Free Cash Flow Margin is Increasing

-583% > -458%

Negative ROE

-49%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-118%

ROIC is Increasing

-159% > -71%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.